Miren L. Baroja

3.1k total citations
45 papers, 2.4k citations indexed

About

Miren L. Baroja is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Miren L. Baroja has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Miren L. Baroja's work include T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (12 papers) and CAR-T cell therapy research (8 papers). Miren L. Baroja is often cited by papers focused on T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (12 papers) and CAR-T cell therapy research (8 papers). Miren L. Baroja collaborates with scholars based in Canada, United States and Belgium. Miren L. Baroja's co-authors include Jan Ceuppens, Joaquı́n Madrenas, Gregor Reid, Beatriz M. Carreno, Thu Chau, Vincent Ling, Jo Van Damme, Pirkka V. Kirjavainen, K Lorré and Sharareh Hekmat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Miren L. Baroja

44 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miren L. Baroja Canada 27 1.2k 859 437 248 241 45 2.4k
Jaime Darce United States 12 1.9k 1.6× 1.0k 1.2× 444 1.0× 121 0.5× 177 0.7× 13 3.2k
Elizabeth E. Eynon United States 22 1.7k 1.4× 624 0.7× 417 1.0× 224 0.9× 114 0.5× 42 2.6k
Ewan A. Ross United Kingdom 26 1.5k 1.3× 979 1.1× 377 0.9× 191 0.8× 97 0.4× 39 3.0k
Sean Stevens United States 20 1.7k 1.4× 903 1.1× 324 0.7× 402 1.6× 88 0.4× 53 3.3k
Roger Kurlander United States 36 2.4k 2.0× 1.1k 1.3× 887 2.0× 362 1.5× 450 1.9× 85 4.4k
Seema R. Patel United States 23 1.1k 0.9× 560 0.7× 213 0.5× 172 0.7× 325 1.3× 54 2.5k
Tim Willinger United States 21 1.6k 1.3× 710 0.8× 519 1.2× 286 1.2× 123 0.5× 27 2.6k
Anja ten Brinke Netherlands 30 1.6k 1.4× 564 0.7× 474 1.1× 129 0.5× 126 0.5× 107 2.8k
Walid Mourad Canada 33 1.9k 1.6× 775 0.9× 267 0.6× 132 0.5× 66 0.3× 120 3.3k
Deborah A. Lebman United States 19 1.9k 1.5× 774 0.9× 284 0.6× 168 0.7× 55 0.2× 33 3.3k

Countries citing papers authored by Miren L. Baroja

Since Specialization
Citations

This map shows the geographic impact of Miren L. Baroja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miren L. Baroja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miren L. Baroja more than expected).

Fields of papers citing papers by Miren L. Baroja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miren L. Baroja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miren L. Baroja. The network helps show where Miren L. Baroja may publish in the future.

Co-authorship network of co-authors of Miren L. Baroja

This figure shows the co-authorship network connecting the top 25 collaborators of Miren L. Baroja. A scholar is included among the top collaborators of Miren L. Baroja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miren L. Baroja. Miren L. Baroja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bear, Adham S., Mark H. O’Hara, Chong Xu, et al.. (2024). Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors. Journal of Clinical Investigation. 134(21). 12 indexed citations
2.
Sharma, Nitika, Estela Noguera-Ortega, Maria Liousia, et al.. (2023). A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy. Molecular Therapy. 31(12). 3564–3578. 7 indexed citations
3.
Bear, Adham S., Tatiana Blanchard, Michael Ford, et al.. (2021). Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nature Communications. 12(1). 4365–4365. 73 indexed citations
4.
Kasper, Katherine J., Joseph J. Zeppa, Stacey X. Xu, et al.. (2014). Bacterial Superantigens Promote Acute Nasopharyngeal Infection by Streptococcus pyogenes in a Human MHC Class II-Dependent Manner. PLoS Pathogens. 10(5). e1004155–e1004155. 76 indexed citations
5.
Xu, Stacey X., Kevin J. Gilmore, Peter A. Szabo, et al.. (2014). Superantigens Subvert the Neutrophil Response To Promote Abscess Formation and Enhance Staphylococcus aureus SurvivalIn Vivo. Infection and Immunity. 82(9). 3588–3598. 44 indexed citations
6.
Ge, Wei, Jacqueline Arp, Dameng Lian, et al.. (2010). Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection. Transplantation. 90(11). 1145–1156. 55 indexed citations
7.
Ge, Wei, J. Jiang, Miren L. Baroja, et al.. (2009). Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance. American Journal of Transplantation. 9(8). 1760–1772. 204 indexed citations
8.
Kirjavainen, Pirkka V., et al.. (2008). Abnormal Immunological Profile and Vaginal Microbiota in Women Prone to Urinary Tract Infections. Clinical and Vaccine Immunology. 16(1). 29–36. 54 indexed citations
9.
McCully, Michelle L., Miren L. Baroja, Thu Chau, et al.. (2007). Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis. Kidney International. 72(10). 1273–1281. 9 indexed citations
10.
Bueno, Clara, Caitlin D. Lemke, Gabriel Criado, et al.. (2006). Bacterial Superantigens Bypass Lck-Dependent T Cell Receptor Signaling by Activating a Gα11-Dependent, PLC-β-Mediated Pathway. Immunity. 25(1). 67–78. 75 indexed citations
11.
Baroja, Miren L., Lalitha Vijayakrishnan, Estelle Bettelli, et al.. (2002). Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A. The Journal of Immunology. 168(10). 5070–5078. 76 indexed citations
12.
Carreno, Beatriz M., Frann Bennett, Thu Chau, et al.. (2000). CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression. The Journal of Immunology. 165(3). 1352–1356. 216 indexed citations
13.
Baroja, Miren L., L B Cieslinski, Theodore J. Torphy, Ronald L. Wange, & Joaquı́n Madrenas. (1999). Specific CD3ε Association of a Phosphodiesterase 4B Isoform Determines Its Selective Tyrosine Phosphorylation After CD3 Ligation. The Journal of Immunology. 162(4). 2016–2023. 31 indexed citations
14.
Baroja, Miren L., et al.. (1996). T Cell Hyperreactivity to IL-6 in Chronic Nonviremic HBV Carriers Despite Normal IL-6 Receptor or gp130 Expression. Viral Immunology. 9(3). 187–194. 2 indexed citations
15.
Baroja, Miren L., et al.. (1994). CD3- and CD28-Activating Pathways in HCV Infection. Viral Immunology. 7(1). 37–40. 3 indexed citations
16.
Baroja, Miren L., et al.. (1993). Anti-CD3-Activated T Cells from Chronic Nonviremic HBV Carriers Are Hyperreactive to Monocytic Accessory Signals. Clinical Immunology and Immunopathology. 69(2). 180–188. 4 indexed citations
17.
Leon‐Ponte, Matilde, et al.. (1991). Enhanced CD3‐mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 34(4). 459–467. 27 indexed citations
18.
Ceuppens, Jan, Miren L. Baroja, K Lorré, Jo Van Damme, & An Billiau. (1988). Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal.. The Journal of Immunology. 141(11). 3868–3874. 166 indexed citations
19.
Ceuppens, Jan, et al.. (1988). Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects.. Journal of Clinical Investigation. 82(2). 571–578. 50 indexed citations
20.
Blanca, Isaac, et al.. (1987). Helper activity by human large granular lymphocytes inin vitro immunoglobulin synthesis. Journal of Clinical Immunology. 7(5). 356–364. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaime Darce Breakdown of academic impact, for papers by Elizabeth E. Eynon Breakdown of academic impact, for papers by Ewan A. Ross Breakdown of academic impact, for papers by Sean Stevens Breakdown of academic impact, for papers by Roger Kurlander Breakdown of academic impact, for papers by Seema R. Patel Breakdown of academic impact, for papers by Tim Willinger Breakdown of academic impact, for papers by Anja ten Brinke Breakdown of academic impact, for papers by Walid Mourad Breakdown of academic impact, for papers by Deborah A. Lebman
Rankless by CCL
2026